Prognostic reclassification and survival outcomes in intermediate- and poor-risk nonseminomatous germ cell tumors (NSGCT)

被引:0
|
作者
Jobanputra, Kunal Naishadh
Prakash, Gagan
Arora, Amandeep
Jadhav, Bhagyashri
Pal, Mahendra
Pawar, Akash
Dey, Sayak
Bakshi, Ganesh
Murthy, Vedang
Maitre, Priyamvada
Menon, Nandini Sharrel
Shah, Minit Jalan
Menon, Santosh
Popat, Palak
Ringe-Katdare, Aparna
Sable, Nilesh
Agrawal, Archi
Noronha, Vanita
Prabhash, Kumar
Joshi, Amit
机构
[1] Tata Mem Hosp, Mumbai, India
[2] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, India
[3] Tata Mem Hosp, Tata Mem Ctr, Mumbai, India
[4] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Navi Mumbai, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5033
引用
收藏
页数:1
相关论文
共 50 条
  • [21] IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER
    Kawai, Koji
    Oikawa, Takehiro
    Onozawa, Mizuki
    Johraku, Akira
    Sekido, Noritoshi
    Miyanaga, Naoto
    Shimazui, Toru
    Akaza, Hideyuki
    JOURNAL OF UROLOGY, 2009, 181 (04): : 198 - 198
  • [22] Testicular Function in Poor-Risk Nonseminomatous Germ Cell Tumors Treated With Methotrexate, Paclitaxel, Ifosfamide, and Cisplatin Combination Chemotherapy
    Pectasides, D.
    Pectasides, E.
    Papaxoinis, G.
    Skondra, M.
    Gerostathou, M.
    Karageorgopoulou, S.
    Kamposioras, C.
    Tountas, N.
    Koumarianou, A.
    Psyrri, A.
    Macheras, A.
    Economopoulos, T.
    JOURNAL OF ANDROLOGY, 2009, 30 (03): : 280 - 286
  • [23] Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
    King, Jennifer
    Kesler, Kenneth
    Ashkar, Ryan
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] CISPLATIN-BASED (PVB+M) CHEMOTHERAPY IN GOOD-RISK AND POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS
    SAIKIA, T
    HEGDE, U
    ADVANI, S
    RAMAKRISHNAN, G
    KULKARNI, J
    DESAI, PB
    JOURNAL OF SURGICAL ONCOLOGY, 1992, 51 (02) : 100 - 103
  • [25] Severity of bleomycin-induced lung toxicity in Indian patients with intermediate and poor-risk non-seminomatous germ cell tumors (NSGCT): A clinical perspective.
    Gujarathi, Himanshu
    Dhanawat, Aditya
    Jadhav, Bhagyashri
    Tiwari, Atul
    Jobanputra, Kunal Naishadh
    Kriti, Y. C.
    Rane, Pallavi
    Shah, Minit Jalan
    Menon, Nandini Sharrel
    Maitre, Priyamvada
    Pal, Mahendra
    Arora, Amandeep
    Ringe-Katdare, Aparna
    Menon, Santosh
    Prakash, Gagan
    Murthy, Vedang
    Noronha, Vanita
    Prabhash, Kumar
    Tandon, Saneep
    Joshi, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [26] Major prognostic value of modeled AUChCG-AFP, a dynamic kinetic marker characterizing tumor marker decline of nonseminomatous germ cell tumors (NSGCT) intermediate-poor-risk patients according to the IGCCCG
    Boyle, H.
    You, B.
    Fronton, L.
    Ribba, B.
    Girard, P.
    Tranchand, B.
    Tod, M.
    Coquelin, H.
    Droz, J.
    Flechon, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] Prognostic significance of primary tumor morphology on progression-free survival (PFS) in patients (pts) with metastatic nonseminomatous germ cell tumors (NSGCT)
    Fedianin, M.
    Tryakin, A.
    Zakharova, T.
    Fainstein, I.
    Figurin, K.
    Polckii, B.
    Sergeev, Y.
    Garin, A.
    Tjulandin, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 308 - 308
  • [28] Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
    Gillessen, Silke
    Sauve, Nicolas
    Collette, Laurence
    Daugaard, Gedske
    de Wit, Ronald
    Albany, Costantine
    Tryakin, Alexey
    Fizazi, Karim
    Stahl, Olof
    Gietema, Jourik A.
    De Giorgi, Ugo
    Cafferty, Fay H.
    Hansen, Aaron R.
    Tandstad, Torgrim
    Huddart, Robert A.
    Necchi, Andrea
    Sweeney, Christopher J.
    Garcia-Del-Muro, Xavier
    Heng, Daniel Y. C.
    Lorch, Anja
    Chovanec, Michal
    Winquist, Eric
    Grimison, Peter
    Feldman, Darren R.
    Terbuch, Angelika
    Hentrich, Marcus
    Bokemeyer, Carsten
    Negaard, Helene
    Fankhauser, Christian
    Shamash, Jonathan
    Vaughn, David J.
    Sternberg, Cora N.
    Heidenreich, Axel
    Beyer, Jorg
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (14) : 1563 - +
  • [29] SALVAGE CHEMOTHERAPY OF METASTATIC NONSEMINOMATOUS GERM CELL TUMORS (NSGCT): SINGLE INSTITUTE EXPERIENCE
    Fedyanin, M.
    Tryakin, A.
    Zakharova, T.
    Fainstein, I.
    Figurin, K.
    Polockii, B.
    Sergeev, J.
    Garin, A.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 188 - 188
  • [30] High-dose chemotherapy in poor-risk germ-cell tumors
    Nichols, CR
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 1427 - 1427